O-Wang J - Search Results

1

T cell dependent and independent antitumor immunity generated by the expression of Fas ligand on mouse lung carcinoma cells.

Tada Y, O-Wang J, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Tada Y, et al. Int J Mol Med. 2002 Mar;9(3):281-5. Int J Mol Med. 2002. PMID: 11836634

2

Expression of the TNF-alpha gene on mouse lung carcinoma cells suppresses spontaneous lung metastasis without affecting tumorigenicity.

Tada Y, O-Wang J, Takenaga K, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Tada Y, et al. Oncol Rep. 2002 May-Jun;9(3):585-8. Oncol Rep. 2002. PMID: 11956632

3

Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells.

Tada Y, O-Wang J, Seimiya M, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Tada Y, et al. Anticancer Res. 2002 Mar-Apr;22(2A):831-6. Anticancer Res. 2002. PMID: 12014659

4

Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells.

Tada Y, O-Wang J, Takiguchi Y, Tatsumi K, Kuriyama T, Okada S, Tokuhisa T, Sakiyama S, Tagawa M. Tada Y, et al. J Immunol. 2002 Sep 1;169(5):2241-5. doi: 10.4049/jimmunol.169.5.2241. J Immunol. 2002. PMID: 12193688

5

Fas ligand-expressing tumors induce tumor-specific protective immunity in the inoculated hosts but vaccination with the apoptotic tumors suppresses antitumor immunity.

Tada Y, O-Wang J, Wada A, Takiguchi Y, Tatsumi K, Kuriyama T, Sakiyama S, Tagawa M. Tada Y, et al. Cancer Gene Ther. 2003 Feb;10(2):134-40. doi: 10.1038/sj.cgt.7700545. Cancer Gene Ther. 2003. PMID: 12536202

6

T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.

Tada Y, O-Wang J, Yu L, Shimozato O, Wang YQ, Takiguchi Y, Tatsumi K, Kuriyama T, Takenaga K, Sakiyama S, Tagawa M. Tada Y, et al. Cancer Gene Ther. 2003 Jun;10(6):451-6. doi: 10.1038/sj.cgt.7700584. Cancer Gene Ther. 2003. PMID: 12768190

7

The effects of FasL on inflammation and tumor survival are dependent on its expression levels.

Wada A, Tada Y, Kawamura K, Takiguchi Y, Tatsumi K, Kuriyama T, Takenouchi T, O-Wang J, Tagawa M. Wada A, et al. Among authors: o wang j. Cancer Gene Ther. 2007 Mar;14(3):262-7. doi: 10.1038/sj.cgt.7701008. Epub 2006 Oct 20. Cancer Gene Ther. 2007. PMID: 17053813

8

Clast5/Stra13 is a negative regulator of B lymphocyte activation.

Seimiya M, Bahar R, Wang Y, Kawamura K, Tada Y, Okada S, Hatano M, Tokuhisa T, Saisho H, Watanabe T, Tagawa M, O-Wang J. Seimiya M, et al. Biochem Biophys Res Commun. 2002 Mar 22;292(1):121-7. doi: 10.1006/bbrc.2002.6605. Biochem Biophys Res Commun. 2002. PMID: 11890681

9

Stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation: elevated expression in human B lymphomas.

Seimiya M, O-Wang J, Bahar R, Kawamura K, Wang Y, Saisho H, Tagawa M. Seimiya M, et al. Int J Oncol. 2003 Feb;22(2):301-4. Int J Oncol. 2003. PMID: 12527926

10

Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells.

Yu L, Ugai S, O-Wang J, Namba M, Kadomatsu K, Muramatsu T, Matsubara S, Sakiyama S, Tagawa M. Yu L, et al. Oncol Rep. 2003 Sep-Oct;10(5):1301-5. Oncol Rep. 2003. PMID: 12883697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters